Latest filing published 18 Nov 2009 for INOVIO PHARMACEUTICALS, INC., €3,340.
Insider track record
No signal scores available.
Kevin Rassas: trading record in brief
Kevin Rassas is a declared insider of Inovio Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 16 November 2009, with 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 18 November 2009: an option exercise of €3,340, in Inovio Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Rassas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 98,120 shares@ US$0.051Inovio Biomedical Corporation Common StockSEC:0001179110-09-015641:0
- 392,480 shares@ US$0.2038Inovio Biomedical Corporation Common StockSEC:0001179110-09-015641:1
- 117,744 shares@ US$0.3058Inovio Biomedical Corporation Common StockSEC:0001179110-09-015641:2
3 of 3 declarations
